Sangamo Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
26 Sep 23 | Sell€2,836,800 | Biogen Inc. | Company | 6,000,000 | €0.47 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 21,269 | 0.0103% |
Individual Insiders | 1,060,873 | 0.511% |
Public Companies | 14,652,466 | 7.06% |
Institutions | 95,569,960 | 46.1% |
General Public | 96,191,041 | 46.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
20,132,324 | €9.4m | 62.4% | 0.04% | |||
14,652,466 | €6.9m | -17% | no data | |||
14,095,865 | €6.6m | -10.8% | no data | |||
12,599,129 | €5.9m | 0.55% | no data | |||
4,750,875 | €2.2m | 62.3% | 0.01% | |||
4,683,973 | €2.2m | 86.7% | no data | |||
3,206,310 | €1.5m | 6.95% | no data | |||
3,145,878 | €1.5m | 33% | no data | |||
2,708,368 | €1.3m | 0.83% | no data | |||
2,500,000 | €1.2m | 92.5% | 0.01% | |||
2,174,133 | €1.0m | 143% | no data | |||
2,085,255 | €977.8k | 147% | no data | |||
1,372,000 | €643.3k | 0% | 0.09% | |||
1,279,784 | €600.1k | -6.81% | no data | |||
1,266,816 | €594.0k | 6.46% | no data | |||
1,231,296 | €577.4k | -72.8% | no data | |||
1,206,879 | €565.9k | 0% | no data | |||
1,122,599 | €526.4k | 198% | no data | |||
1,075,690 | €504.4k | 92.2% | 0.05% | |||
1,033,322 | €484.5k | 14.4% | no data | |||
1,008,062 | €472.7k | 150% | no data | |||
891,734 | €418.1k | 104% | no data | |||
791,210 | €371.0k | -30.8% | no data | |||
716,528 | €336.0k | 0% | no data | |||
575,065 | €269.7k | -28.5% | no data |